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The predicted amino acid sequence of the human cytomegalovirus UL97 protein bears partial homology to the herpes
simplex virus 1 UL13 protein, especially in regions that are homologous to conserved domains characteristic of protein
kinases. Earlier studies showed that UL13 mediated the posttranslational processing of several herpes simplex virus 1
proteins including ICP22. Whereas no kinase activity has been specifically attributed to UL13, it has been shown that UL97
can phosphorylate ganciclovir. To examine whether UL97 can substitute for UL13, we constructed a herpes simplex virus
1 recombinant virus, R4970, in which UL13 was replaced by UL97 and in addition, the thymidine kinase gene was deleted.
Characterization of this recombinant virus showed the following: (1) The recombinant virus grew as well as the wild-type
virus in BHKTK/ cells, which restricted the growth of the UL130 virus. (2) UL97 could partially mediate the posttranslational
modification of HSV-1 ICP22. This modification correlated with the restoration of the amounts of ICP0 and US11 proteins,
which were down regulated in the UL130 virus-infected cells. (3) The recombinant virus was sensitive to ganciclovir in Vero-
and KHOS-infected cells but not in the 143 thymidine kinase minus cells derived from KHOS cells. Vero cells infected with
this recombinant virus phosphorylated ganciclovir. We conclude that UL97 partially compensates for UL13 functions.
q 1996 Academic Press, Inc.
INTRODUCTION subset of late gene products accumulate in smaller
amounts than in wild-type-infected cells and in addition,
This report concerns the UL13 gene of herpes simplex both the protein and the RNA of the promiscuous trans-
virus 1 (HSV-1) and its homolog, the UL97 gene of human activator, ICP0, accumulate in smaller amounts than in
cytomegalovirus (HCMV). cells infected with wild-type virus. These phenotypic
The sequence of the HSV-1 UL13 gene reported by properties of the UL13
0 virus suggest that UL13 plays aMcGeoch et al. (1988) was predicted to encode a protein major regulatory role in viral gene expression. Analyses
with the hallmarks of a protein kinase (Smith and Smith, of the function of UL13 protein have been hampered by1989). The UL13 gene is dispensable for growth of HSV- the inability to demonstrate its protein kinase activity
1 in cultured cells (Purves and Roizman, 1992). Indeed, directly in vitro. Specifically, attempts to express the pro-
comparisons of the phosphoprotein profiles of the wild- tein in a variety of prokaryotic cells or in insect cells were
type and UL13
0 virus-infected cells revealed that several not successful (F. Purves and B. Roizman, unpublished
viral proteins were not phosphorylated in UL13
0 virus- studies) possibly because of the toxicity of the UL13 pro-
infected cells. Two functions related to the UL13 protein tein expressed in these cells.
are of particular interest. The first relates to the function The predicted sequence of the HCMV UL97 protein
of infected cell protein No. 22 or ICP22. This protein, a bears partial amino acid homology to the HSV-1 UL13
product of the a gene 22 (a22), is a highly processed protein and like the latter, it is expected to encode a
phosphoprotein in that it is both phosphorylated and protein kinase (Chee et al., 1989). The natural substrate
nucleotidylylated (Ackermann et al., 1984; Blaho et al., of the UL97 protein is not known; however, the protein has
1993). A number of specific ICP22 phosphoprotein bands been reported to phosphorylate the nucleoside analog
appear to be absent in electrophoretically separated ly- ganciclovir (Littler et al., 1992; Sullivan et al., 1992). Spe-
sates of cells infected with UL13
0 virus (Purves and Roiz- cifically, HCMV is inhibited by ganciclovir although, un-
man, 1992). Concurrently, the UL13
0 virus-infected cells like HSV-1, the virus does not encode a thymidine kinase
exhibit some of the phenotypes of cells infected with a (tk) capable of phosphorylating the drug (Biron et al.,
recombinant virus lacking the carboxyl half of ICP22 1985). The evidence that UL97 protein may phosphorylate
(Purves et al., 1993; Sears et al., 1985). Specifically, a the drug first emerged from mapping of the mutated gene
responsible for resistance to ganciclovir (Biron et al.,
1986; Sullivan et al., 1992). Subsequently, UL97 protein1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (312) 702-1631. has been shown to phosphorylate ganciclovir directly in
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TABLE 1
Genotype and Phenotype of Recombinant Viruses Used in This Study
Virusa Genotypeb Phenotypec
HSV-1(F) Wild-type TK/, UL13/
HSV-1(F)D305 DUL23/DUL24 TK0, UL13/
R7354 DUL23/DUL24, UL13i TK/, UL130
R7355 DUL23/DUL24, DUL13 TK0, UL130
R7356 DUL13 TK/, UL130
R7358 DUL23/DUL24, UL13R TK0, UL13/
R4969 DUL23/DUL24(R), DUL13, HCMV-UL97 TK/, UL130, UL97/
R4970 DUL23/DUL24, DUL13, HCMV-UL97 TK0, UL130, UL97/
R325-bTK/ Da22 TK/, UL13/, ICP220
a Constructions of recombinant viruses HSV-1(F)D305, R7354, R7355, R7356, R7358, and R325-bTK/ were reported elsewhere; R4969 and R4970
were constructed in these studies.
b D, gene containing deletion; i, the chimeric a27tk gene was inserted into the UL13 open reading frame; R, wild-type sequences restored in the
mutant.
c TK, thymidine kinase.
vitro, indicating that it can act as a kinase (Littler et al., Growth assays
1992). In light of the limited homology between UL97 and Growth assays were done on BHKTK/ cells as de-
UL13 (Chee et al., 1989), the shared hallmarks of a kinase, scribed previously (Sears et al., 1985). Briefly, confluent
and the evidence that UL97 can act as a kinase in vitro, replicate cultures of BHKTK/ cells were exposed to ei-
the question arose as to whether UL97 could substitute ther 0.02 or 20 PFU of parent or mutant viruses per cell.
for UL13. After a 2-hr adsorption interval, cells were washed three
In the studies described in this report, we constructed
times with medium 199-V consisting of mixture 199 sup-
and characterized a recombinant HSV-1 virus in which
plemented with 1% calf serum and incubated at 377. Cells
UL13 was replaced by UL97. We report that UL97 can exposed to 20 PFU/cell were harvested 24 hr after infec-
substitute for, albeit partially, the functions of the UL13 tion. Cells exposed to 0.02 PFU/cell were harvested 3
protein. We also show that UL97 confers partial gan- days after infection. Virus stocks were titrated on repli-
ciclovir sensitivity to a recombinant virus, which lacks
cate Vero cell cultures under the 199-O overlay con-
both the UL13 and tk genes, but only in cells which are sisting of mixture 199 supplemented with 1% calf serum
capable of expressing the native thymidine kinase.
and 0.2% pooled human immune gamma globulin.
MATERIALS AND METHODS Construction of plasmids
Cells and viruses The construction of plasmids pRB4437 and pRB4090
carrying the HSV-1(F) sequences encoding UL13 openVero, BHKTK/, and KHOS (also known as R970-5) cell
reading frame and promoter of the UL26.5 coding se-lines were obtained from the American Type Culture Col-
quence, respectively, were reported elsewhere (Liu andlection. The rabbit skin cells and the 143TK0 cell lines
Roizman, 1991a; Purves and Roizman, 1992). The double-were originally obtained from John McClaren and Carlo
stranded DNA oligomer linker (5*-GTA ACC GCT GCACroce (Croce et al., 1979), respectively. HSV-1(F) is the
GGA TAT CG-3* and its complement 5*-GTT ACC GATprototype strain used in this laboratory (Ejercito et al.,
ATC CTG CAG CG-3*) was inserted into the BstEII site of1968). The constructions of HSV-1 recombinant viruses
the UL13 sequence in plasmid pRB4437 to yield plasmidHSV-1(F)D305, R7354, R7355, R7358, and R325-bTK/
pRB4967. Another double-stranded DNA oligomer linkerwere reported elsewhere (Post et al., 1981; Purves and
(5*-GTG ACC GCT GCA GGA TAT CG-3* and its comple-Roizman, 1992; Sears et al., 1985). R7356 was con-
ment 5*-GTC ACC GAT ATC CTG CAG CG-3*) was in-structed by F. Purves (unpublished studies). Table 1 lists
serted into the BstEII site of the UL26.5 promoter se-the genotypes of all the viruses used in this study.
quence in plasmid pRB4090 to yield plasmid pRB4968.
By inserting these oligomer linkers, an EcoRV cloningChemicals
site was introduced next to the BstEII sequences in both
vectors. pRB4967 was then digested with HindIII and[8-3H]Ganciclovir (14.9 Ci/mmol) was obtained from
Moravek Biochemicals (Brea, CA). The mono-, di-, and EcoRV to remove the 773-bp sequence that encodes the
conserved protein kinase domains of UL13. The deletedtriphosphates of ganciclovir were synthesized by meth-
ods described previously (Ertl et al., 1995). sequence was replaced by the 882-bp HindIII– EcoRV
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fragment of UL26.5 promoter sequence from plasmid vitrogen) and the ligation products were used to trans-
form competent INVaF* cells. Plasmid DNA from the re-pRB4968 to yield plasmid pRB4969. Plasmid pRB4976
was constructed by subcloning the 3.5-kbp EcoRI–Hin- sulting white colonies was isolated using purification col-
umns (Qiagen) and was screened for UL97 inserts bydIII (HCMV genomic coordinates 139,495–142,993) from
a HCMV cosmid into cloning vector pGEM-3Zf(/) (Pro- digestion with BglII and EcoRI. The BglII–EcoRI UL97
fragment was gel purified and ligated to BglII–EcoRI cutmega). The HCMV cosmid, a kind gift of Bernhard Fleck-
enstein, contains the HCMV HindIII fragments L-c-b-U- pVL1392 plasmid. The ligated DNA was transformed into
competent DH5a cells and the transformants were plateda-P-S (Fleckenstein et al., 1982). pRB4976 was subse-
quently digested with HincII and NruI, and the 2.6-kbp on LB-ampicillin plates. A clone containing UL97
(pVLUL97-2) was sequenced to ensure that the correctfragment containing the entire HCMV UL97 gene was
inserted into the EcoRV site in plasmid pRB4969 to yield UL97 DNA was present. pVLUL97-2 was cotransfected
with wild-type AcNPV DNA into Sf9 cells using standardpRB4970.
calcium phosphate transfection procedures (O’Reilly et
Construction of HSV-1 recombinant viruses al., 1992). UL97 protein expressed from the infected cells
was separated on a 9% polyacrylamide gel and the UL97Recombinant viruses were constructed as described
band was excised from the gel. Rabbits were injected
in details elsewhere (Post and Roizman, 1981). Briefly,
subcutaneously with a mixture of acrylamide gel con-
R4970 virus was constructed by cotransfection of rabbit
taining UL97 protein and PBS and were boosted fourskin cells with intact R7354 viral DNA and plasmid DNA
times. Antisera were collected after the first, second, and
of pRB4970. The progeny of the transfections were plated
fourth boosts.
on 143TK0 cells in the presence of bromodeoxyuridine
(100 mg/ml) to select for thymidine kinase minus (tk0) Extraction of UL97 from baculovirus-infected cellsviruses. Individual plaques were picked and plaque puri-
fied on Vero cells. The presence of the appropriate viral Sf9 cells in a 150-cm2 culture flask were infected with
pVLUL97-2 recombinant virus at a multiplicity of 0.5. In-DNA fragments was verified by hybridization of electro-
phoretically separated BglII and HindIII digested viral fected cells were incubated at 277 for 3 days, collected,
and pelleted. Infected cells were resuspended in lysisDNA with 32P-labeled probes prepared by nick translation
of plasmids pRB4004 or pRB4976. pRB4004 contains the buffer (50 mM Tris, pH 7.5, 1% NP-40, 10% glycerol, 2
mM EDTA, 50 mM DTT, 0.1 mM PMSF, and 10 mg/mlBglIIO fragment of the HSV-1(F) (Fig. 1, line 2). To repair
the sequences deleted from the UL23 (tk gene) and UL24 each of aprotinin and leupeptin). The suspension was
freeze-thawed once and then centrifuged at 5000 g. Theopen reading frames of R4970, intact R4970 viral DNA
was cotransfected with plasmid p816 DNA into rabbit pellet was extracted further with 0.25 ml lysis buffer con-
taining 0.3 M NaCl, 20 mg/ml RNase, and 40 mg/mlskin cells. Plasmid p816 contains the HSV-1(F) BamHIQ
fragment in the pUC9 vector. The progeny of the transfec- DNase. For immunoblot analysis, 1 ml of the cell pellet
was suspended in disruption buffer and loaded onto ations were plated on 143TK0 cells overlaid with HAT
medium, which is 199 medium supplemented with hypo- polyacrylamide gel.
xanthine, aminopterin, thymidine, and 1% calf serum to
Electrophoretic separation and immunoblottingselect for thymidine kinase plus (tk/) viruses. Individual
of viral proteinsplaques were picked and plaque purified on Vero cells
and the genotypes were verified by hybridization of elec-
Replicate 25-cm2 flask cultures of rabbit skin cells or
trophoretically separated BamHI restriction endonucle-
Vero cells were exposed to 20 PFU parent or mutant
ase digested viral DNA with 32P-labeled DNA of plasmid
viruses per cell and maintained at 377 for 24 hr. For the
p816. The virus selected for further studies was desig-
time course experiment, infected cells were harvested
nated R4969.
19, 22, or 24 hr after infection. To detect ICP22, ICP0,
US11, or ICP27, infected cells were harvested, pelletedConstruction of UL97 expression vector and antibody by low speed centrifugation, rinsed in PBS.A (0.14 Mproduction
NaCl, 3 mM KCl, 10 mM Na2HPO4 , 1.5 mM KH2PO4) and
resuspended in 200 ml of disruption buffer (12.5 mM Tris–The entire UL97 gene of AD169 was PCR-amplified
from HCMV DNA using the following primers: UL97-1 (5*- HCl (pH 6.8), 0.5% SDS, 2.5% glycerol, 5% b-mercaptoeth-
anol). Approximately half of each sample was loadedTCT TCT AGA TCT GAC TGT CGC CAC TAT GTC CTC-
3*) and UL97-10 (5*-TCT TCT GAA TTC TTA GAA CTC onto each lane of a denaturing 8.5% polyacrylamide gel.
For the detection of HCMV UL97 in HSV-1 recombinantCTC CTC GGG GAA CAG TTG GCG GCA-3*). UL97-1
creates a BglII site in the noncoding region of UL97 and viruses, the infected cell cultures were solubilized in 100
ml of disruption buffer and the entire sample was sub-UL97-10 contains a sequence that encodes a Glu-Glu-
Phe recognition sequence. The resulting 2.3-kbp PCR jected to electrophoresis. In all instances, the electropho-
retically separated polypeptides were electrically trans-product was ligated into the TA vector pCR1000 (In-
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ferred to nitrocellulose membrane (Schleicher and PFU of parent or mutant viruses and incubated at 377
for 2 hr. The inoculum was then replaced with mediumSchuell) and reacted with the appropriate antibodies. The
bound antibody was visualized with a second anti-mouse containing ganciclovir in concentration of 0, 1, 5, 10, or
25 mg/ml. Cells were overlaid with different media inor anti-rabbit IgG antibody conjugated to alkaline phos-
phatase (Bio-Rad). The rabbit polyclonal antibody R77 order to improve the morphology of the plaques in differ-
ent cells. For Vero, 143TK0, and KHOS cells, the overlaydirected against ICP22 and the monoclonal antibody to
US11 were described elsewhere (Ackermann et al., 1984; media were 199-O, DME-2%FCS-O (DME supplemented
with 2% fetal calf serum and 0.2% pooled human immuneRoller and Roizman, 1992). Monoclonal antibodies to
ICP0 (H1083) or ICP27 (H1117) described by Ackermann gamma globulin), and 199-2%FCS-O (199 supplemented
with 2% fetal calf serum and 0.2% pooled human immuneet al. (1984) were purchased from Goodwin Institute
(Plantation, FL). gamma globulin), respectively. The infected monolayers
were fixed with methanol and stained with Giemsa Stain
Metabolic labeling of infected cells 2 days after infection.
Replicate Vero cell cultures were exposed to 20 PFU
Yield reduction assayof parent or mutant viruses per cell in the presence of
Actinomycin D (5 mg/ml). At 3 hr postinfection, the cells Replicate 25-cm2 flask cultures of 143TK0 cells were
were overlaid with 1 ml of medium deficient in methio- infected with either HSV-1(F), R7355, or R4970 virus at a
nine but supplemented with 50 mCi of [35S]methionine multiplicity of 10. After adsorption at 377 for 2 hr, the
(sp act, 1000 Ci/mmol; Amersham, Arlington Heights, inoculum was replaced with DME medium supplemented
IL) for 1 hr. The cells were then solubilized and subjected with 2% fetal calf serum and containing ganciclovir in
to electrophoresis in 12% denaturing polyacrylamide gels concentration of 0, 0.3, 3, 30, or 150 mM. Infected cells
and autoradiography. In addition, the radioactivity in the were harvested 18 hr after infection. Virus stocks were
bands containing actin was quantified in a Betagen Beta- then titrated on replicate Vero cell cultures. After 2 hr of
scope. adsorption, the infected Vero cells were rinsed two times
with 199-O and then incubated in 199-O for 2 days. The
RNA analyses infected cells were fixed with methanol and stained with
Giemsa Stain.Replicate 150-cm2 flask cultures of Vero cells were
exposed to 10 PFU of parent or mutant viruses per cell
Analysis of intracellular ganciclovir metabolitesin the presence of Actinomycin D (5 mg/ml). At 3 hr after
infection, total RNA was extracted from the infected cells Vero cells grown on 60-mm2 culture dishes were
as described elsewhere (Puissant and Houdebine, 1990) either mock-infected or infected with HSV-1(F), R7355,
and digested with amplification grade DNase (Gibco- or R4970 virus at a multiplicity of 10. At 8 hr postinfec-
BRL) according to manufacturer’s instruction. For the de- tion, infected and mock-infected cells were pulsed with
tection of the actin transcript, one-seventh of the sample [8-3H]ganciclovir (5 mM) for 15 hr. Cells were washed
(approximately 12 mg of RNA) was denatured and loaded with cold PBS, extracted with ice-cold 80% acetonitrile
onto each lane in a 1.5% agarose gel containing formal- for 5 min, and the cells were scraped from the dishes.
dehyde. For the detection of the 28S rRNA, approximately Extracts were clarified by centrifugation at 770 g for
1.2 mg of RNA was loaded onto each lane of the agarose 15 min at 47. Supernatants were evaporated to dryness
gel. RNA was subsequently separated electrophoreti- and reconstituted in high-pressure liquid chromatogra-
cally and transferred to a Zeta-probe membrane (Bio- phy (HPLC)-grade water at a concentration of 1.0 1
Rad) in 101 SSC (1.5 M NaCl and 0.15 M trisodium 106 cells/120 ml.
citrate). DNA probes specific to actin and 28S rRNA were Following degradation of potentially interfering ribonu-
prepared by nick translation of the appropriate plasmids. cleotides using a modified periodate oxidation procedure
Plasmid containing a cDNA clone of human cytoplasmic (Garrett and Santi, 1979), cellular extracts were analyzed
actin was obtained from E. Fuchs (Hanukoglu et al., by anion-exchange HPLC using a modification of the
1983). Plasmid p983, a kind gift of Joany Chou, contains method described previously (Paff et al., 1994). A perio-
the 240-bp EcoRI– BamHI sequence PCR-amplified from date-treated sample (200 ml) was applied to a Partisil
the DNA sequence encoding the 28S rRNA. After hybrid- SAX column (10 mm, 250 1 4.6 mm) (Alltech Associates,
ization with the probes, the blot was examined in a Beta- Inc., Deerfield, IL) equilibrated in 10 mM ammonium
gen Betascope, and the amounts of radioactivity in the phosphate, pH 3.8, containing 2.5 mM KCl/5 mM MgCl2/
actin and 28S rRNA bands were quantified. 10% ethanol (buffer A). It was eluted with a gradient from
buffer A to 250 mM ammonium phosphate, pH 2.5, con-
Plaque reduction assay
taining 250 mM KCl/100 mM MgCl2/10% ethanol/5% ace-
tonitrile (buffer B) at 1 ml/min as follows: (i) 30-min iso-Replicate 25-cm2 flask cultures of Vero, 143TK0, or
KHOS cells were each exposed to approximately 200 cratic elution with 100% buffer A, (ii) 10-min linear gradi-
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FIG. 1. Schematic representations of DNA sequence arrangements of the HSV-1 recombinant viruses used in this study. Line 1, schematic
representation of the genome of HSV-1(F)D305, from which approximately 500 bp of the domains of UL23 (thymidine kinase) and UL24 had
been deleted. The rectangles represent the inverted repeat sequences ab and b*a* flanking the unique long (UL) sequence (thin line), and
a*c* and ca flanking the short (US) sequence (thin line). Line 2, the BglII O fragment and the relevant restriction enzyme sites in the genome
domain encoding UL12, UL13, and UL14 open reading frames. Line 3, R7354, the parent of recombinant virus R4970 contains the a27tk
chimeric gene inserted at the BstEII site of UL13 (Purves and Roizman, 1992). Line 4, the a27tk gene inserted into UL13 of recombinant
virus R7354 was replaced with the coding sequence of HCMV UL97 fused to the promoter of the UL26.5 gene (pUL26.5). Bg, BglII; B, BstEII;
H, HindIII.
ent from 100% buffer A to 65% buffer A/35% buffer B, (iii) fragment in the BglII O fragment of HSV-1(F) was re-
placed with the pUL26.5-UL97 chimeric gene to yield20-min linear gradient to 55% buffer A/45% buffer B, (iv)
pRB4970. The recombinant virus R4970 (Fig. 1, line 4)5-min linear gradient to 35% buffer A/65% buffer B, (v)
was obtained by cotransfection of rabbit skin cells with25-min linear gradient to 25% buffer A/75% buffer B, and
intact R7354 (Fig. 1, line 3) viral DNA and plasmid(vi) 5-min linear gradient to 100% buffer B. The UV ab-
pRB4970 as described under Materials and Methods.sorbance of the column effluent was monitored at 254
We have selected the UL26.5 promoter because earliernm, and 1-ml fractions were collected for radioactivity
studies have shown that it is suitable for high level ex-measurement by liquid scintillation counting. The column
pression of genes embedded in the HSV-1 genome (Liuwas reequilibrated in 100% buffer A for 15 min prior to
and Roizman, 1991b).injection of another sample. Peaks of radioactivity were
The structure of recombinant virus R4970 was veri-identified as metabolites based on correspondence to
fied by hybridization of electrophoretically separatedthe retention times of authentic standards and were
DNA digests, as described under Materials and Meth-quantitated based on the specific activity of drug in the
ods, with nick-translated pRB4004 (Fig. 2A) andpulse media.
pRB4976 (Fig. 2B) probes. Plasmid pRB4004 contains
the HSV-1 BglIIO fragment that encompasses the se-
RESULTS
quence of UL13, and plasmid pRB4976 contains the
HCMV EcoRI – HindIII sequence containing UL97. TheConstruction of a HSV-1 recombinant virus carrying the
higher intensity of the image in lane 1 (Fig. 2A) wasHCMV UL97 gene in place of the HSV-1 UL13 gene
due to the production of a poorly resolved 2.6-kbp dou-
The objective of these series of experiments was to blet after digestion of the BglIIO fragment with HindIII
replace the coding domain of UL13 with a chimeric gene and BglII. The insertion of the a27tk chimeric gene at
capable of expressing the HCMV UL97 gene. In earlier UL13 in R7354 increased the size of one of the 2.6-kbp
studies, this laboratory reported the construction of a bands to 4.4-kbp (Fig. 2A, lane 2). In R4970, the a27tk
UL13
0 virus by deletion of the HindIII– BstEII fragment of insertion was deleted by recombination, but the 2.6-
the HSV-1(F) BglII O fragment (Purves and Roizman, kbp band increased in size to 5.3 kbp because of the
insertion of the pUL26.5-UL97 chimeric gene. The pres-1992). In these series of experiments, the HindIII–BstEII
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Moreover, the electrophoretic mobility of the baculovirus-
made UL97 protein was identical to that of the UL97 pro-
tein made in HCMV-infected human foreskin fibroblasts
(a gift of George Kemble, Aviron, data not shown). UL97
was not present in mock-infected cells or cells infected
with HSV-1(F)D305 (Fig. 3, lanes 2, 3, 5, and 6). The
expression of UL97 varied from one cell line to the other.
It was higher in rabbit skin cells (Fig. 3, lane 4) than
in Vero cells (Fig. 3, lane 7). We conclude that R4970
recombinant virus expresses the HCMV UL97 protein.
Growth of UL97 recombinant virus in BHKTK/ cell line
Earlier studies have shown that UL13
0 and ICP220
viruses were impaired with respect to growth in rodent
cell lines (Purves et al., 1993; Sears et al., 1985). To
determine if UL97 could substitute for the role of UL13 in
growth, the 500 bp deleted from the domain of the tk
gene and affecting both UL23 and UL24 open reading
frames in R4970 virus was repaired by marker rescue
with the HSV-1(F) BamHI Q DNA fragment as previously
described to yield the recombinant R4969 (data notFIG. 2. Autoradiographic images of BglII–HindIII digests of recombi-
shown). This ensured that the phenotype of R4969 wasnant viral DNA. (A) Viral DNA digested with BglII and HindIII was elec-
trophoretically separated in a 0.8% agarose gel, transferred to Zeta- attributable directly to the replacement of UL13 by UL97.
Probe membrane, and hybridized with 32P-labeled pRB4004 containing The replication of R4969 was then compared with those
the HSV-1 (F) BglII O fragment. The 2.6-kbp doublet in lane 1 represents of other tk/ viruses, i.e., HSV-1(F), R7356 (UL130), andthe BglII O fragment digested by HindIII in HSV-1(F)D305. The 4.4-kbp
R325-bTK/ (ICP220) viruses with respect to their capaci-fragment in lane 2 contains the a27-tk gene inserted at the BstEII site
ties to yield infectious progeny viruses in BHKTK/ cellsof UL13. The 5.3-kbp band detected in lane 3 corresponds to the BglII–
HindIII fragment with the BstEII –HindIII 773-bp sequence of the UL13 (Table 2). Although the BHKTK/ cells appeared to be
gene replaced by the DNA sequences encoding the UL26.5 promoter more permissive than the Rat-1 cells tested previously
(882 bp) and the HCMV UL97 gene (2.6 kbp). (B) After autoradiography, (Sears et al., 1985), results from all of the three experi-
the membrane was stripped of radioactivity and reprobed with pRB4976
ments suggested that in cells exposed to either 20 orcarrying the HCMV EcoRI–HindIII fragment harboring the UL97 gene.
0.02 PFU/cell, the yields of UL13
0 or ICP220 viruses wereThe 32P-labeled pRB4976 DNA sequence hybridized only with the 5.3-
kbp band containing the HCMV UL97 sequence (lane 3). smaller than those of the wild-type parent. In contrast,
the yield of R4969 tended to be higher than that of the
wild-type virus. In individual experiments, the ratio of
ence of UL97 sequence in the 5.3-kbp band was con- yields of R4969 to any of the deletion mutants was at
firmed by hybridization with the pRB4976 probe (Fig. least 2.5 and in many instances 10.
2B, lane 3).
Production of UL97 antibody and verification of
expression of UL97 by the R4970 recombinant virus
To detect the expression of UL97 protein by the R4970
recombinant virus, an antibody directed against UL97
was produced. To meet this objective, UL97 was overex-
pressed in insect cells infected with a recombinant bacu-
lovirus carrying the gene and injected into a rabbit to
raise anti-UL97 polyclonal antibody. In immunoblots, the
rabbit antiserum reacted with the UL97 protein expressed FIG. 3. Photograph of electrophoretically separated polypeptides re-
in insect cells infected with the recombinant baculovirus acted with anti-UL97 antibody. Replicate cultures of rabbit skin cells
(lanes 2–4) or Vero cells (lanes 5–7) were either mock infected or(Fig. 3, lane 1) and with a protein with a mobility similar
infected with HSV-1(F)D305 or with R4970 (UL130, UL97/) virus. Theto that of the recombinant UL97 protein in cells infected
infected cells were harvested at 24 hr after infection, solubilized, sub-with R4970 (Fig. 3, lanes 4 and 7). The apparent Mr of jected to electrophoresis in a denaturing polyacrylamide gel, electri-
the recombinant UL97 proteins expressed in infected- cally transferred to nitrocellulose sheet, and reacted with the anti-UL97
insect cells and R4970-infected cells was approximately antiserum. Lane 1 contained an extract from Sf9 insect cells infected
with a baculovirus expressing recombinant HCMV UL97 protein (RUL97).80,000, which is the predicted Mr of the UL97 protein.
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TABLE 2
Replication of Recombinant Viruses in BHKTK/ Cellsa
Experiment 1 Experiment 2 Experiment 3
Ratio
virus/cell Virus Yield %b Yield %b Yield %b
20 HSV-1(F) 2.4 1 108 100 1.1 1 108 100 5.3 1 108 100
R7356 4.5 1 107 19 2.1 1 107 19 3.4 1 108 64
R325-bTK/ 3.4 1 107 14 2.7 1 107 25 1.9 1 108 36
R4969 4.9 1 108 204 2.2 1 108 200 1.1 1 109 207
0.02 HSV-1(F) 7.5 1 108 100 2.0 1 108 100 2.1 1 109 100
R7356 2.0 1 108 27 9.0 1 106 5 4.3 1 108 20
R325-bTK/ 6.0 1 108 80 1.5 1 107 8 2.0 1 108 10
R4969 1.7 1 109 227 3.8 1 108 190 2.4 1 109 114
a BHKTK/ cells were infected with recombinant viruses at multiplicities of 20 or 0.02 PFU per cell as described in the text. The infected cell
cultures were harvested and titrated on Vero cells.
b Relative to the yield of HSV-1(F).
Complementation of UL13
0 phenotype by UL97 gene ICP22 contained in cells infected with UL13
0, UL97
/ virus
formed the fast migrating bands characteristic of ICP22product
made in UL13
0 virus-infected cells and a new set of upper
Earlier studies have shown that UL13 mediated directly bands (Fig. 4, lane 4). The top doublet of ICP22 in UL13
0,
or indirectly the posttranslational processing of ICP22,
UL97
/ virus had the same mobility but was lower in abun-
and that in the absence of UL13, the levels of ICP0, and dance than that of the wild-type virus. The intermediate
of a subset of late proteins (e.g., US11), were reduced form of ICP22 present in the wild-type virus was absent
(Purves and Roizman, 1992; Purves et al., 1993). Modifica-
in UL13
0, UL97
/ virus.
tion of ICP22 and expression levels of ICP0 and US11 in (ii) Several experiments not shown yielded no evi-
UL13
0, UL97
/ virus-infected cells were determined in two
dence of posttranslational modification of ICP22 in cells
series of experiments to address the question whether
infected with UL13
0, UL97
/ virus until late in infection.
UL97 could substitute for UL13.
The first series of experiments concerned itself with
the modification of ICP22. As described elsewhere,
ICP22 from cells infected with wild-type virus formed at
least five readily detectable bands in denaturing poly-
acrylamide gels, whereas ICP22 isolated from cells in-
fected with UL13
0 virus formed a smaller number of faster
migrating bands (Ackermann et al., 1984; Purves and
Roizman, 1992). To determine whether UL97 can substi-
tute for UL13 in the modification of ICP22, lysates of in-
fected rabbit skin cells harvested 24 hr (Fig. 4) or different
time points (Fig. 5) after infection were solubilized, sub-
jected to electrophoresis in denaturing polyacrylamide
gels, transferred to a nitrocellulose membrane, and re-
acted with a polyclonal antiserum to ICP22 (R77) or
monoclonal antibody to ICP27. The accumulation of
ICP27 was shown previously to be unaffected by the
absence of UL13 and therefore it was used as an internal
control for equal loading (Purves et al., 1993). All viruses
used in these experiments were tk0. The results were
FIG. 4. Electrophoretic profiles of ICP0, ICP22, ICP27, and US11 madeas follows:
in rabbit skin cells infected with parent and mutant viruses. Replicate
cultures of rabbit skin cells were either mock infected or infected with(i) The ICP22 from cells infected with HSV-1(F)D305
HSV-1(F)D305, R7355 (UL130), or R4970 (UL130, UL97/). The infectedformed five distinct bands as expected (Fig. 4, lane 2).
cells were harvested at 24 hr after infection, solubilized, electrophoreti-In contrast, ICP22 from UL13
0 virus-infected cells exhib-
cally separated in a denaturing polyacrylamide gel, electrically trans-
ited at least one and possibly two bands, migrating faster ferred to a nitrocellulose sheet, and reacted with R77 antiserum (ICP22)
than those formed by wild-type virus (Fig. 4, lane 3). and monoclonal antibodies H1083 (ICP0), CL28 (US11), and H1117
(ICP27).Moreover, the slow migrating bands were missing. The
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FIG. 5. Electrophoretic profiles of ICP0, ICP22, and ICP27 made in rabbit skin cells infected with parent and mutant viruses at different times
after infection. Replicate cultures of rabbit skin cells were either mock infected or infected with HSV-1(F)D305, R7355 (UL130), or R4970 (UL130,
UL97/). The infected cells were harvested at 19, 22, or 24 hr after infection, solubilized, electrophoretically separated in a denaturing polyacrylamide
gel, electrically transferred to nitrocellulose sheet, and reacted with R77 antiserum (ICP22) and monoclonal antibodies H1083 (ICP0) and H1117
(ICP27).
The results of the time course experiment done on in- (Overton et al., 1994). To determine if UL97 was able to
fected rabbit skin cells (Fig. 5) showed that the modifica- restore viral host shutoff in UL13
0 virus-infected cells, the
tion of ICP22 occurred gradually rather late, from 19 to level of synthesis of a representative cellular protein,
24 hr after infection. Thus, the time-course of ICP22 modi- actin, and the amount of its RNA transcript was measured
fication in UL13
0, UL97
/ virus-infected cells was slower in two series of experiments.
than that observed in wild-type virus-infected cells. As In the first series, replicate cultures of Vero cells were
shown in Fig. 4, in the presence of UL97 infected cells exposed to parent and mutant viruses for 3 hr in the
accumulated relatively small amounts of ICP22 which presence of actinomycin D and then incubated in me-
comigrated with the slow migrating forms of ICP22 made dium containing actinomycin D and [35S]methionine. In-
in the parent virus-infected cells. The delayed modifica- fected cells were then harvested, solubilized, subjected
tion of ICP22 may in part reflect the fact that UL97 expres- to electrophoresis in denaturing gels, and subjected to
sion was under the HSV-1 g1 promoter of UL26.5. This autoradiography as described under Materials and Meth-
promoter may be activated later than the native UL13 ods. The radioactivity specifically associated with actin,
promoter. We conclude from this experiment that UL97 a representative cellular protein, was quantified in a Be-
mediates the modification of ICP22, but that this modifi- tagen Betascope. As shown in Fig. 6, the autoradio-
cation may be less extensive and possibly different from graphic image of actin shows that the parent virus re-
that taking place in wild-type virus-infected cells. duced the amount of actin synthesized during the label-
ing interval to approximately 36% of the amount madeThe second series of experiments concerned itself
in mock-infected cells. In UL13
0 virus-infected cells, thewith the expression of ICP0 and of US11 protein. As re-
amount of actin synthesized during the labeling intervalported previously, both ICP0 and US11 proteins accumu-
was approximately 59% of the amount made in mock-lated to lower levels in the UL13
0 virus-infected cells than
infected cells. The quantities of actin made in cells in-the wild-type virus (Fig. 4, lane 3 and Fig. 5, lanes 3, 7,
fected with viruses which carried a repaired UL13 geneand 11) (Purves et al., 1993). The relative amounts of
(UL13R) or UL97 in place of UL13 could not be differenti-ICP0 and US11 proteins accumulating in cells infected
ated from those infected with the wild-type virus.with UL13
0, UL97
/ virus could not be differentiated from
HSV-1 mediates shutoff of host protein synthesis bythose contained in parent virus-infected cells and were
higher than those present in UL13
0 virus-infected cells degradation of the cellular mRNA. Therefore, the tran-
(Fig. 4, lane 4 and Fig. 5, lanes 4, 8, and 12). script of actin was examined in the second series of
experiments. Replicate cultures of Vero cells were ex-
The UL97 recombinant virus restores host shutoff posed to parent and mutant viruses in the presence of
function diminished in UL13
0 virus-infected cells actinomycin D and then incubated in medium containing
actinomycin D. At 3 hr after infection, RNA of the infectedElsewhere it has been reported that mutants lacking
an intact UL13 gene were defective in host shutoff cells was extracted, subjected to electrophoresis, and
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hybridized with excess 32P-labeled probes to actin and
28S ribosomal RNA as described under Materials and
Methods. The amounts of both species of RNA were
quantified in a Betagen Betascope. To control for extrac-
tion and loading of RNA, the amounts of actin-specific
RNA were normalized to the amounts of 28S rRNA. The
results (Fig. 7) were as follows: (i) Cells infected with
the parent virus contained 40% of the actin-specific RNA
recovered from mock-infected cells. (ii) Cells infected
with UL13
0 virus contained 60% of the amounts of actin-
specific RNA in mock-infected cells. (iii) The amounts
of actin-specific RNA recovered from cells infected with
UL13
0, UL97
/, and UL13R viruses were comparable to
that recovered from wild-type virus-infected cells.
Ganciclovir sensitivity of UL97 recombinant virus
As discussed in the introduction, HCMV resistance to
FIG. 7. Autoradiographic image of electrophoretically separatedganciclovir has been mapped to mutations in the UL97
RNA hybridized to excess actin and 28S rRNA probes. Replicategene and extensive studies have demonstrated that UL97
cultures of Vero cells were either mock infected or infected with
can mediate the phosphorylation of this drug (Littler et HSV-1(F)D305, R4970 (UL130, UL97/), R7355 (UL130), or R7358
al., 1992; Stanat et al., 1991; Sullivan et al., 1992). Gan- (UL13R) virus in the presence of Actinomycin D. The cells were har-
ciclovir is also phosphorylated by the HSV-1 thymidine vested at 3 hr after mock-infection or infection. Total RNA was ex-
tracted from infected cells, separated on 1.5% agarose gel, andkinase and inhibits viral DNA synthesis. It was of interest
transferred to Zeta-probe membrane as described under Materialsto determine whether UL13 or UL97 confer upon HSV-
and Methods. The membrane was then reacted with labeled DNA
infected cells sensitivity to ganciclovir in the absence of probes of actin (A) or 28S rRNA (B). The amounts of radioactivity in
both viral and cellular thymidine kinases. The experimen- each lane were quantified in a Betagen Betascope. The relative
tal design described under Materials and Methods con- percentage of actin RNA in infected cells relative to that of the mock-
infected cells was calculated on the basis of total 28S rRNA recov-sisted of a plaque reduction assay in which monolayers
ered from the same cells.of TK/ or TK0 cells were infected with approximately
200 PFU of wild-type and mutant viruses and maintained
in the presence of increasing concentrations of gan-
ciclovir. We tested three cell lines, i.e., Vero, a human (i) HSV-1(F) (wild-type) and R7356 (TK/, UL130) wereTK/ cell line, KHOS, another human TK/ cell line, and sensitive to ganciclovir in all cell lines tested.
143TK0, a TK0 cell line derived from the KHOS cell line
(ii) HSV-1(F)D305 (TK0, UL13/) and R7355 (TK0,(Croce et al., 1979). The results (Fig. 8) were as follows:
UL13
0) were resistant to ganciclovir in all cell lines
tested.
(iii) UL97 expressed in the context of the HSV-1 ge-
nome (R4970) conferred partial sensitivity to ganciclovir
in Vero and KHOS cell lines but not in 143TK0 cell line.
To confirm the insensitivity of R4970 to ganciclovir in
143TK0 cell line, a yield reduction assay was carried out.
The growth of HSV-1(F), R7355, and R4970 viruses on
143TK0 cells was first confirmed to be the same before
the assay (data not shown). For the yield reduction assay,
143TK0 cells infected with each virus were incubated in
FIG. 6. Autoradiographic image of [35S]methionine radiolabeled in- increasing concentrations of ganciclovir for 18 hr and the
fected cell lysate. Replicate cultures of Vero cells were either mock
infected cells were titrated on Vero cells. The effectiveinfected or infected with HSV-1(F)D305, R7355 (UL130), R7358 (UL13R),
dose 90% (ED90) of HSV-1(F) was 0.3 mM while that ofor R4970 (UL130, UL97/) virus in the presence of Actinomycin D. At 3
hr after infection, the cells were labeled by [35S]methionine for 1 hr. R4970 was 50 mM (Fig. 9). The ED90 of R7355 was greater
Cells were then solubilized and electrophoretically separated in a dena- than 150 mM.
turing polyacrylamide gel. The amounts of radioactivity of actin in each The difference in the sensitivity of R4970 to ganciclovirlane were quantified in a Betagen Betascope and the relative percent-
in the different infected cell lines was not due to a differ-age of actin in each lane was calculated relative to the amount in the
lane of the mock-infected cells. ence in the expression level of the protein. The expres-
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sitivity to the drug in the three cell lines in which the
tests were done.
Phosphorylation of ganciclovir by UL97 recombinant
virus
Previous studies with HCMV clinical isolates have indi-
cated a correlation between the intracellular levels of
ganciclovir phosphates and in vitro susceptibilities to the
drug (Stanat et al., 1991). To determine whether the gan-
ciclovir susceptibility of the R4970 virus also correlated
with the intracellular phosphorylation of the drug, an
anabolism study was performed. HSV-1(F), R4970, R7355,
or mock-infected cells were incubated with medium con-
taining [8-3H]ganciclovir starting at 8 hr postinfection.
After 15 hr of incubation, the ganciclovir anabolites were
extracted from the cells and quantitated by HPLC. As
expected, the wild-type HSV expressing functional thymi-
dine kinase efficiently induced ganciclovir phosphates
(Table 3). Cells infected with R7355 contained levels just
above those measured in the uninfected cells, while cells
infected with R4970 accumulated levels approximately
20 times higher than the R7355-infected cultures. These
FIG. 8. Effect of ganciclovir on plaque formation of parent and
mutant viruses in Vero, 143TK0, and KHOS (143TK/) cells. Replicate
25-cm2 flask cultures were infected with approximately 200 PFU of
HSV-1(F) (wild type), R7355 (TK0, UL130), R4970 (TK0, UL130, UL97/),
HSV-1(F)D305 (TK0, UL13/), or R7356 (TK/, UL130) viruses. After
adsorption, the cells were overlaid with medium containing pooled
human immune gamma globulin and either 0, 1, 5, 10 or 25 mg of
ganciclovir per milliliter as described under Materials and Methods.
At 48 hr after infection, the cultures were rinsed with phosphate-
buffered saline, fixed with methanol, and stained with Giemsa stain
to visualize the plaques.
FIG. 9. Effect of ganciclovir on viral yields of parent and mutant
viruses in 143TK0 cells. Replicate 25-cm2 flask cultures of 143TK0 cells
sion of UL97 in 143TK
0-infected cells was comparable to were infected with 10 PFU of HSV-1(F) (wild type), R7355 (TK0, UL130),
that in infected Vero cells (data not shown). or R4970 (TK0, UL130, UL97/) viruses. After adsorption, the cells were
overlaid with media containing 0, 0.3, 3, 30, or 150 mM of ganciclovirWe conclude that R4970 is sensitive to ganciclovir in
as described under Materials and Methods. At 18 hr after infection,the TK/ Vero and KHOS cell lines but not in 143TK0
the cultures were harvested and titrated on Vero cells. A and B repre-cell line derived from the KHOS cell line. Furthermore, sent results of two individual experiments. The plots show virus yields
comparison of UL13/ and UL130 viruses indicated that as a function of ganciclovir concentration relative to virus yields in the
absence of the drug.UL13 did not confer upon HSV-1 significant levels of sen-
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TABLE 3 hypothesis that UL97 mediated the modification of ICP22
more slowly than UL13 or that it was made and accumu-Phosphorylation of [8-3H]Ganciclovir in Infected Vero Cellsa
lated later in infection than the UL13 protein.
Ganciclovir anabolites (iii) Earlier studies have indicated that in UL13
0 virus-
Virus (pmol/million cells) infected cells, the effect on the expression of ICP0 and
a subset of late genes exemplified by US11 is due to theMock 0.17
lack of posttranscriptional modification of ICP22 ratherHSV-1(F) 75.04
than to the absence of UL13 inasmuch as the phenotypeR7355 0.49
R4970 10.07 of UL13
0 virus was similar to that of a virus carrying a
truncated a22 gene (Purves et al., 1993). These consider-
a At 8 hr postinfection, the infected and mock-infected cells were labeled ations lead us to suggest that (a) the restoration of ICP0
for 15 hr with [8-3H]ganciclovir. The ganciclovir anabolites extracted from
and of US11 protein levels in UL13
0, UL97/ virus-infectedcells were measured using HPLC as described under Materials and Meth-
cells is due to the effect of UL97 on ICP22 and (b) thatods.
the modification of ICP22 mediated by UL97 is sufficient
to enable the accumulation of ICP0 and US11 proteins to
results indicate that the ganciclovir sensitivity of R4970 the level found in wild-type virus-infected cells.
recombinant virus was due to the phosphorylation of gan- (iv) UL97 confers partial ganciclovir sensitivity to the
ciclovir by UL97 protein. UL13
0, tk0, UL97/ virus in TK/ cell lines, but not in a
related TK0 cell line. Two issues are relevant here. First,
DISCUSSION wild-type HSV-1 is far more sensitive to ganciclovir than
UL13
0, tk0, UL97/ virus. The simplest explanation forBoth the HSV-1 UL13 and the HCMV UL97 proteins this observation may rest on the observation that cells
share hallmarks of protein kinases. The role of UL13 in infected with wild-type virus are far more efficient in
the expression of a subset of HSV-1 proteins has been
phosphorylating ganciclovir than UL13
0, tk0, UL97/ virus-demonstrated earlier (Purves et al., 1993) and it could be
infected cells.
expected that in principle virally encoded protein kinases
The second and more baffling observation is that the
like UL13 and UL97 would play a regulatory role by medi- UL13
0, tk0, UL97/ virus was sensitive to ganciclovir inating the posttranslational processing of viral and cellular
cell lines capable of expressing cellular thymidine ki-
proteins. The question we have attempted to resolve
nase, but not in 143TK0 cell line. This observation con-
stems in part from the fact that HSV-1 and HCMV belong
trasts with the report by Metzger et al. (1994) that a re-
to different subfamilies of herpesviridae. While we can
combinant tk0 vaccinia virus expressing UL97 was morereadily recognize conserved genes in members of both
sensitive to ganciclovir than the parental virus in infected
families, the extent of homology is rather limited. Since
143TK0 cells. One possible explanation is that UL97 con-kinases could be expected to recognize specific features
verts ganciclovir to ganciclovir-monophosphate and that
of their substrates, the question arose whether UL97 other cellular enzymes convert this product to di- and
could substitute for UL13. The salient features of the re- triphosphates. Cell lines selected for TK0 phenotype may
sults and their implications are as follows:
have lost the capacity to convert ganciclovir-monophos-
phate to ganciclovir-triphosphate, whereas this function(i) UL97 can substitute for the UL13 gene in overall
aspects of viral replication inasmuch as the UL13
0, was conserved in vaccinia virus from which the tk gene
had been deleted.UL97/ virus grows as well as the wild-type parent in a
cell line that restricts the growth of the UL13
0 virus. As noted in the introduction, UL13 possesses the hall-
marks of a protein kinase, but direct evidence to support(ii) UL97 protein mediates, but only in part, the post-
translational modification of HSV-1 ICP22. The electro- the hypothesis that the modifications mediated by UL13
reflect a protein kinase activity has been lacking. In thisphoretic profile of ICP22 from cells infected with UL13
0,
UL97
/ virus was different from that of cells infected with report we show that a related protein, with a proven
kinase activity, substitutes at least in part for the func-the parent, UL13/ virus. One hypothesis which could
explain these results is that both the nature and the tions of UL13 protein. By extension, the modifications of
proteins mediated by UL13 may be the consequences ofnumber of amino acid residues modified by UL97 are
different from those modified by UL13. If this were the direct phosphorylation by this protein.
case, it could be expected that the domains of ICP22
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